Cargando…

Effectiveness and scalability of an electronic patient-reported outcome measure and decision support tool for family-centred and participation-focused early intervention: PROSPECT hybrid type 1 trial protocol

INTRODUCTION: Early intervention (EI) endorses family-centred and participation-focused services, but there remain insufficient options for systematically enacting this service approach. The Young Children’s Participation and Environment Measure electronic patient-reported outcome (YC-PEM e-PRO) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaelin, Vera, Villegas, Vivian, Chen, Yi-Fan, Murphy, Natalie, Papautsky, Elizabeth, Litfin, Jodi, Leland, Natalie, Maheshwari, Varun, McManus, Beth, Khetani, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728410/
https://www.ncbi.nlm.nih.gov/pubmed/34983760
http://dx.doi.org/10.1136/bmjopen-2021-051582
_version_ 1784626727962542080
author Kaelin, Vera
Villegas, Vivian
Chen, Yi-Fan
Murphy, Natalie
Papautsky, Elizabeth
Litfin, Jodi
Leland, Natalie
Maheshwari, Varun
McManus, Beth
Khetani, Mary
author_facet Kaelin, Vera
Villegas, Vivian
Chen, Yi-Fan
Murphy, Natalie
Papautsky, Elizabeth
Litfin, Jodi
Leland, Natalie
Maheshwari, Varun
McManus, Beth
Khetani, Mary
author_sort Kaelin, Vera
collection PubMed
description INTRODUCTION: Early intervention (EI) endorses family-centred and participation-focused services, but there remain insufficient options for systematically enacting this service approach. The Young Children’s Participation and Environment Measure electronic patient-reported outcome (YC-PEM e-PRO) is an evidence-based measure for caregivers that enables family-centred services in EI. The Parent-Reported Outcomes for Strengthening Partnership within the Early Intervention Care Team (PROSPECT) is a community-based pragmatic trial examining the effectiveness of implementing the YC-PEM e-PRO measure and decision support tool as an option for use within routine EI care, on service quality and child outcomes (aim 1). Following trial completion, we will characterise stakeholder perspectives of facilitators and barriers to its implementation across multiple EI programmes (aim 2). METHODS AND ANALYSIS: This study employs a hybrid type 1 effectiveness-implementation study design. For aim 1, we aim to enrol 223 caregivers of children with or at risk for developmental disabilities or delays aged 0–3 years old that have accessed EI services for three or more months from one EI programme in the Denver Metro catchment of Colorado. Participants will be invited to enrol for 12 months, beginning at the time of their child’s annual evaluation of progress. Participants will be randomised using a cluster-randomised design at the EI service coordinator level. Both groups will complete baseline testing and follow-up assessment at 1, 6 and 12 months. A generalised linear mixed model will be fitted for each outcome of interest, with group, time and their interactions as primary fixed effects, and adjusting for child age and condition severity as secondary fixed effects. For aim 2, we will conduct focus groups with EI stakeholders (families in the intervention group, service coordinators and other service providers in the EI programme, and programme leadership) which will be analysed thematically to explain aim 1 results and identify supports and remaining barriers to its broader implementation in multiple EI programmes. ETHICS AND DISSEMINATION: This study has been approved by the institutional review boards at the University of Illinois at Chicago (2020-0555) and University of Colorado (20-2380). An active dissemination plan will ensure that findings have maximum reach for research and practice. TRIAL REGISTRATION NUMBER: NCT04562038.
format Online
Article
Text
id pubmed-8728410
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-87284102022-01-18 Effectiveness and scalability of an electronic patient-reported outcome measure and decision support tool for family-centred and participation-focused early intervention: PROSPECT hybrid type 1 trial protocol Kaelin, Vera Villegas, Vivian Chen, Yi-Fan Murphy, Natalie Papautsky, Elizabeth Litfin, Jodi Leland, Natalie Maheshwari, Varun McManus, Beth Khetani, Mary BMJ Open Paediatrics INTRODUCTION: Early intervention (EI) endorses family-centred and participation-focused services, but there remain insufficient options for systematically enacting this service approach. The Young Children’s Participation and Environment Measure electronic patient-reported outcome (YC-PEM e-PRO) is an evidence-based measure for caregivers that enables family-centred services in EI. The Parent-Reported Outcomes for Strengthening Partnership within the Early Intervention Care Team (PROSPECT) is a community-based pragmatic trial examining the effectiveness of implementing the YC-PEM e-PRO measure and decision support tool as an option for use within routine EI care, on service quality and child outcomes (aim 1). Following trial completion, we will characterise stakeholder perspectives of facilitators and barriers to its implementation across multiple EI programmes (aim 2). METHODS AND ANALYSIS: This study employs a hybrid type 1 effectiveness-implementation study design. For aim 1, we aim to enrol 223 caregivers of children with or at risk for developmental disabilities or delays aged 0–3 years old that have accessed EI services for three or more months from one EI programme in the Denver Metro catchment of Colorado. Participants will be invited to enrol for 12 months, beginning at the time of their child’s annual evaluation of progress. Participants will be randomised using a cluster-randomised design at the EI service coordinator level. Both groups will complete baseline testing and follow-up assessment at 1, 6 and 12 months. A generalised linear mixed model will be fitted for each outcome of interest, with group, time and their interactions as primary fixed effects, and adjusting for child age and condition severity as secondary fixed effects. For aim 2, we will conduct focus groups with EI stakeholders (families in the intervention group, service coordinators and other service providers in the EI programme, and programme leadership) which will be analysed thematically to explain aim 1 results and identify supports and remaining barriers to its broader implementation in multiple EI programmes. ETHICS AND DISSEMINATION: This study has been approved by the institutional review boards at the University of Illinois at Chicago (2020-0555) and University of Colorado (20-2380). An active dissemination plan will ensure that findings have maximum reach for research and practice. TRIAL REGISTRATION NUMBER: NCT04562038. BMJ Publishing Group 2022-01-04 /pmc/articles/PMC8728410/ /pubmed/34983760 http://dx.doi.org/10.1136/bmjopen-2021-051582 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Paediatrics
Kaelin, Vera
Villegas, Vivian
Chen, Yi-Fan
Murphy, Natalie
Papautsky, Elizabeth
Litfin, Jodi
Leland, Natalie
Maheshwari, Varun
McManus, Beth
Khetani, Mary
Effectiveness and scalability of an electronic patient-reported outcome measure and decision support tool for family-centred and participation-focused early intervention: PROSPECT hybrid type 1 trial protocol
title Effectiveness and scalability of an electronic patient-reported outcome measure and decision support tool for family-centred and participation-focused early intervention: PROSPECT hybrid type 1 trial protocol
title_full Effectiveness and scalability of an electronic patient-reported outcome measure and decision support tool for family-centred and participation-focused early intervention: PROSPECT hybrid type 1 trial protocol
title_fullStr Effectiveness and scalability of an electronic patient-reported outcome measure and decision support tool for family-centred and participation-focused early intervention: PROSPECT hybrid type 1 trial protocol
title_full_unstemmed Effectiveness and scalability of an electronic patient-reported outcome measure and decision support tool for family-centred and participation-focused early intervention: PROSPECT hybrid type 1 trial protocol
title_short Effectiveness and scalability of an electronic patient-reported outcome measure and decision support tool for family-centred and participation-focused early intervention: PROSPECT hybrid type 1 trial protocol
title_sort effectiveness and scalability of an electronic patient-reported outcome measure and decision support tool for family-centred and participation-focused early intervention: prospect hybrid type 1 trial protocol
topic Paediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728410/
https://www.ncbi.nlm.nih.gov/pubmed/34983760
http://dx.doi.org/10.1136/bmjopen-2021-051582
work_keys_str_mv AT kaelinvera effectivenessandscalabilityofanelectronicpatientreportedoutcomemeasureanddecisionsupporttoolforfamilycentredandparticipationfocusedearlyinterventionprospecthybridtype1trialprotocol
AT villegasvivian effectivenessandscalabilityofanelectronicpatientreportedoutcomemeasureanddecisionsupporttoolforfamilycentredandparticipationfocusedearlyinterventionprospecthybridtype1trialprotocol
AT chenyifan effectivenessandscalabilityofanelectronicpatientreportedoutcomemeasureanddecisionsupporttoolforfamilycentredandparticipationfocusedearlyinterventionprospecthybridtype1trialprotocol
AT murphynatalie effectivenessandscalabilityofanelectronicpatientreportedoutcomemeasureanddecisionsupporttoolforfamilycentredandparticipationfocusedearlyinterventionprospecthybridtype1trialprotocol
AT papautskyelizabeth effectivenessandscalabilityofanelectronicpatientreportedoutcomemeasureanddecisionsupporttoolforfamilycentredandparticipationfocusedearlyinterventionprospecthybridtype1trialprotocol
AT litfinjodi effectivenessandscalabilityofanelectronicpatientreportedoutcomemeasureanddecisionsupporttoolforfamilycentredandparticipationfocusedearlyinterventionprospecthybridtype1trialprotocol
AT lelandnatalie effectivenessandscalabilityofanelectronicpatientreportedoutcomemeasureanddecisionsupporttoolforfamilycentredandparticipationfocusedearlyinterventionprospecthybridtype1trialprotocol
AT maheshwarivarun effectivenessandscalabilityofanelectronicpatientreportedoutcomemeasureanddecisionsupporttoolforfamilycentredandparticipationfocusedearlyinterventionprospecthybridtype1trialprotocol
AT mcmanusbeth effectivenessandscalabilityofanelectronicpatientreportedoutcomemeasureanddecisionsupporttoolforfamilycentredandparticipationfocusedearlyinterventionprospecthybridtype1trialprotocol
AT khetanimary effectivenessandscalabilityofanelectronicpatientreportedoutcomemeasureanddecisionsupporttoolforfamilycentredandparticipationfocusedearlyinterventionprospecthybridtype1trialprotocol
AT effectivenessandscalabilityofanelectronicpatientreportedoutcomemeasureanddecisionsupporttoolforfamilycentredandparticipationfocusedearlyinterventionprospecthybridtype1trialprotocol